UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

IL-15 Enhances the in vivo Antitumor Activity of Tumor-Reactive CD8+T Cells

Proceedings of the National Academy of Sciences - PNAS, 2004-02, Vol.101 (7), p.1969-1974

2004

Volltextzugriff (PDF)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

The Journal of experimental medicine, 2005-10, Vol.202 (7), p.907-912

2005

Volltextzugriff (PDF)

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells

The Journal of experimental medicine, 2003-08, Vol.198 (4), p.569-580

2003

Volltextzugriff (PDF)

Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

Journal of leukocyte biology, 2004-08, Vol.76 (2), p.333-337

2004

Volltextzugriff (PDF)

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Nature medicine, 1998-03, Vol.4 (3), p.321-327

1998

Volltextzugriff (PDF)

De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.1105-1113

2006

Volltextzugriff (PDF)

Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine

The Journal of immunology (1950), 1999-08, Vol.163 (3), p.1690-1695

1999

Volltextzugriff (PDF)

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

The Journal of immunology (1950), 2002-01, Vol.168 (1), p.338-347

2002

Volltextzugriff (PDF)

Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (18), p.5957-5961

2003

Volltextzugriff (PDF)

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium

Journal of immunotherapy (1997), 2002-05, Vol.25 (3), p.218

2002

Volltextzugriff (PDF)

Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice

Cancer research (Chicago, Ill.), 1994-08, Vol.54 (15), p.4155-4161

1994

Volltextzugriff (PDF)

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (8), p.1741-1747

1995

Volltextzugriff (PDF)

Potential Use of T Cell Receptor Genes to Modify Hematopoietic Stem Cells for the Gene Therapy of Cancer

Pathology oncology research, 1999-03, Vol.5 (1), p.3-15

1999

Volltextzugriff (PDF)

Interferon γ and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

The Journal of experimental medicine, 1991-03, Vol.173 (3), p.647-658

1991

Volltextzugriff (PDF)

A nonimmunogenic sarcoma transduced with the cDNA for interferon γ elicits CD8+ T cells against the wild-type tumor : correlation with antigen presentation capability

The Journal of experimental medicine, 1992-06, Vol.175 (6), p.1423-1431

1992

Volltextzugriff (PDF)

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2

The Journal of experimental medicine, 1985-05, Vol.161 (5), p.1169-1188

1985

Volltextzugriff (PDF)

De novo induction of a cancer/testis antigen by 5-aza.2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model

Cancer research (Chicago, Ill.), 2006, Vol.66 (2), p.1105-1113

2006

Volltextzugriff (PDF)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 super(+) T cells

The Journal of experimental medicine, 2005-10, Vol.202 (7), p.907-912

2005

Volltextzugriff (PDF)

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation: studies on the mechanism of action

The Journal of experimental medicine, 1990, Vol.171 (1), p.249-263

1990

Volltextzugriff (PDF)

Combination Immunotherapy for Cancer:Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating Lymphocytes

JNCI : Journal of the National Cancer Institute, 1988-11, Vol.80 (17), p.1393-1397

1988

Volltextzugriff (PDF)

A simplified method for the production of murine T-cell growth factor free of lectin

Journal of immunological methods, 1981-01, Vol.42 (2), p.213-222

1981

Volltextzugriff (PDF)

In vivo administration of Interleukin-2 enhances specific alloimmune responses

Transplantation, 1983-06, Vol.35 (6), p.631

1983

Volltextzugriff (PDF)

In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2

JNCI : Journal of the National Cancer Institute, 1987-11, Vol.79 (5), p.1067-1075

1987

Volltextzugriff (PDF)

In vitro growth of murine T cells. I. Production of factors necessary for T cell growth

The Journal of immunology (1950), 1978-11, Vol.121 (5), p.1946

1978

Volltextzugriff (PDF)

In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens

The Journal of immunology (1950), 1978-11, Vol.121 (5), p.1951

1978

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IL-15 Enhances the in vivo Antitumor Activity of Tumor-Reactive CD8+T Cells

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells

Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model

Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium

Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses

Potential Use of T Cell Receptor Genes to Modify Hematopoietic Stem Cells for the Gene Therapy of Cancer

Interferon γ and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

A nonimmunogenic sarcoma transduced with the cDNA for interferon γ elicits CD8+ T cells against the wild-type tumor : correlation with antigen presentation capability

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2

De novo induction of a cancer/testis antigen by 5-aza.2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 super(+) T cells

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation: studies on the mechanism of action

Combination Immunotherapy for Cancer:Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating Lymphocytes

A simplified method for the production of murine T-cell growth factor free of lectin

In vivo administration of Interleukin-2 enhances specific alloimmune responses

In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2

In vitro growth of murine T cells. I. Production of factors necessary for T cell growth

In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens

Suchergebnisse filtern